These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 1680815)
1. Combined in vitro modulation of adriamycin resistance. Meijer C; Mulder NH; Timmer-Bosscha H; Peters WH; de Vries EG Int J Cancer; 1991 Oct; 49(4):582-6. PubMed ID: 1680815 [TBL] [Abstract][Full Text] [Related]
2. Contribution of glutathione and glutathione-dependent enzymes in the reversal of adriamycin resistance in colon carcinoma cell lines. Lai GM; Moscow JA; Alvarez MG; Fojo AT; Bates SE Int J Cancer; 1991 Nov; 49(5):688-95. PubMed ID: 1682279 [TBL] [Abstract][Full Text] [Related]
3. P-glycoprotein and alterations in the glutathione/glutathione-peroxidase cycle underlie doxorubicin resistance in HL-60-R, a subclone of the HL-60 human leukemia cell line. Raghu G; Pierre-Jerome M; Dordal MS; Simonian P; Bauer KD; Winter JN Int J Cancer; 1993 Mar; 53(5):804-11. PubMed ID: 8095491 [TBL] [Abstract][Full Text] [Related]
4. Mechanisms and modulation of multidrug resistance in primary human renal cell carcinoma. Mickisch GH; Roehrich K; Koessig J; Forster S; Tschada RK; Alken PM J Urol; 1990 Sep; 144(3):755-9. PubMed ID: 1974934 [TBL] [Abstract][Full Text] [Related]
5. The role of glutathione in resistance to cisplatin in a human small cell lung cancer cell line. Meijer C; Mulder NH; Hospers GA; Uges DR; de Vries EG Br J Cancer; 1990 Jul; 62(1):72-7. PubMed ID: 2390486 [TBL] [Abstract][Full Text] [Related]
6. Mitomycin C sensitivity in human bladder cancer cells: possible role of glutathione and glutathione transferase in resistance. Xu BH; Gupta V; Singh SV Arch Biochem Biophys; 1994 Jan; 308(1):164-70. PubMed ID: 8311448 [TBL] [Abstract][Full Text] [Related]
7. Reduced DNA topoisomerase II activity and drug-induced DNA cleavage activity in an adriamycin-resistant human small cell lung carcinoma cell line. de Jong S; Zijlstra JG; de Vries EG; Mulder NH Cancer Res; 1990 Jan; 50(2):304-9. PubMed ID: 1967222 [TBL] [Abstract][Full Text] [Related]
8. Overexpression of glutathione S-transferase and elevation of thiol pools in a multidrug-resistant human colon cancer cell line. Chao CC; Huang YT; Ma CM; Chou WY; Lin-Chao S Mol Pharmacol; 1992 Jan; 41(1):69-75. PubMed ID: 1346333 [TBL] [Abstract][Full Text] [Related]
9. Relationship of cellular glutathione to the cytotoxicity and resistance of seven platinum compounds. Meijer C; Mulder NH; Timmer-Bosscha H; Sluiter WJ; Meersma GJ; de Vries EG Cancer Res; 1992 Dec; 52(24):6885-9. PubMed ID: 1458477 [TBL] [Abstract][Full Text] [Related]
10. Multifactorial resistance in LS174T human colon carcinoma cells selected with doxorubicin. Rabier MJ; Bruno NA; Slate DL Int J Cancer; 1991 Oct; 49(4):601-7. PubMed ID: 1680816 [TBL] [Abstract][Full Text] [Related]
11. A study of the mechanism of resistance to Adriamycin in vivo. Glutathione metabolism, P-glycoprotein expression, and drug transport. Lee FY; Sciandra J; Siemann DW Biochem Pharmacol; 1989 Nov; 38(21):3697-705. PubMed ID: 2574574 [TBL] [Abstract][Full Text] [Related]
12. Glutathione as a determinant of cellular response to doxorubicin. Lee FY; Vessey AR; Siemann DW NCI Monogr; 1988; (6):211-5. PubMed ID: 3352767 [TBL] [Abstract][Full Text] [Related]
13. Combined effects of buthionine sulfoximine and cepharanthine on cytotoxic activity of doxorubicin to multidrug-resistant cells. Kisara S; Furusawa S; Murata R; Ogata M; Hikichi N; Takayanagi Y; Sasaki K Oncol Res; 1995; 7(3-4):191-200. PubMed ID: 8555653 [TBL] [Abstract][Full Text] [Related]
14. Characterization of adriamycin-resistant human breast cancer cells which display overexpression of a novel resistance-related membrane protein. Chen YN; Mickley LA; Schwartz AM; Acton EM; Hwang JL; Fojo AT J Biol Chem; 1990 Jun; 265(17):10073-80. PubMed ID: 1972154 [TBL] [Abstract][Full Text] [Related]
15. Circumvention of drug resistance in cisplatin-resistant sublines of the human squamous carcinoma cell line HLac 79 in vitro and in vivo. Bier H Acta Otolaryngol; 1991; 111(4):797-806. PubMed ID: 1950544 [TBL] [Abstract][Full Text] [Related]
16. Effect of buthionine sulfoximine on toxicity of verapamil and doxorubicin to multidrug resistant cells and to mice. Ford JM; Yang JM; Hait WN Cancer Res; 1991 Jan; 51(1):67-72. PubMed ID: 1988108 [TBL] [Abstract][Full Text] [Related]
17. Identification of glutathione S-transferase as a determinant of 4-hydroperoxycyclophosphamide resistance in human breast cancer cells. Chen G; Waxman DJ Biochem Pharmacol; 1995 May; 49(11):1691-701. PubMed ID: 7786310 [TBL] [Abstract][Full Text] [Related]
18. Role of free radicals in an adriamycin-resistant human small cell lung cancer cell line. Meijer C; Mulder NH; Timmer-Bosscha H; Zijlstra JG; de Vries EG Cancer Res; 1987 Sep; 47(17):4613-7. PubMed ID: 3040227 [TBL] [Abstract][Full Text] [Related]
19. Overcoming tumor necrosis factor-alpha resistance of human renal and ovarian carcinoma cells by combination treatment with buthionine sulfoximine and tumor necrosis factor-alpha. Role of tumor necrosis factor-alpha mRNA down-regulation in tumor cell sensitization. Mizutani Y; Yoshida O Cancer; 1994 Feb; 73(3):730-7. PubMed ID: 8299097 [TBL] [Abstract][Full Text] [Related]
20. Buthionine sulphoximine-mediated sensitisation of etoposide-resistant human breast cancer MCF7 cells overexpressing the multidrug resistance-associated protein involves increased drug accumulation. Schneider E; Yamazaki H; Sinha BK; Cowan KH Br J Cancer; 1995 Apr; 71(4):738-43. PubMed ID: 7710938 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]